| scholarly article | Q13442814 |
| P50 | author | Sabine Rüsch-Gerdes | Q30002009 |
| Stefan Niemann | Q30011787 | ||
| Thomas A Kohl | Q53678284 | ||
| Lanfranco Fattorini | Q56424438 | ||
| Helen Cox | Q38641538 | ||
| Marco R. Oggioni | Q42137324 | ||
| P2093 | author name string | Elvira Richter | |
| Andreas Roetzer | |||
| Francis Varaine | |||
| Leona Truebe | |||
| Matthias Merker | |||
| P2860 | cites work | Mechanism of thioamide drug action against tuberculosis and leprosy | Q24676495 |
| The Beijing genotype and drug resistant tuberculosis in the Aral Sea region of Central Asia | Q24814887 | ||
| Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis | Q28343859 | ||
| Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis | Q28344564 | ||
| Genomic diversity among drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis with identical DNA fingerprints | Q28476294 | ||
| Treatment of tuberculosis in a region with high drug resistance: outcomes, drug resistance amplification and re-infection | Q28476640 | ||
| Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients | Q28482730 | ||
| Whole genome sequencing versus traditional genotyping for investigation of a Mycobacterium tuberculosis outbreak: a longitudinal molecular epidemiological study | Q28709007 | ||
| The magic bullets and tuberculosis drug targets. | Q30350532 | ||
| Systematic analysis of pyrazinamide-resistant spontaneous mutants and clinical isolates of Mycobacterium tuberculosis | Q30419570 | ||
| Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study | Q31107101 | ||
| VarDetect: a nucleotide sequence variation exploratory tool | Q33393974 | ||
| Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates | Q33970864 | ||
| Evolution of high mutation rates in experimental populations of E. coli | Q34429727 | ||
| High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. | Q34508854 | ||
| Drug-susceptible Mycobacterium tuberculosis Beijing genotype does not develop mutation-conferred resistance to rifampin at an elevated rate | Q34975227 | ||
| Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection | Q35006626 | ||
| Overexpression of the D-alanine racemase gene confers resistance to D-cycloserine in Mycobacterium smegmatis | Q35627816 | ||
| Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes. | Q35635595 | ||
| Deep resequencing of serial sputum isolates of Mycobacterium tuberculosis during therapeutic failure due to poor compliance reveals stepwise mutation of key resistance genes on an otherwise stable genetic background. | Q53442441 | ||
| Role of mutator alleles in adaptive evolution. | Q54564129 | ||
| Exclusive mutations related to isoniazid and ethionamide resistance among Mycobacterium tuberculosis isolates from Korea | Q57216216 | ||
| Characteristics of drug-resistant tuberculosis in Abkhazia (Georgia), a high-prevalence area in Eastern Europe | Q60441794 | ||
| Drug susceptibility of Mycobacterium tuberculosis Beijing genotype and association with MDR TB. | Q35844623 | ||
| Microevolution of extensively drug-resistant tuberculosis in Russia | Q35864738 | ||
| Mycobacterium tuberculosis population structure determines the outcome of genetics-based second-line drug resistance testing | Q35941443 | ||
| Mycobacterium tuberculosis thymidylate synthase gene thyX is essential and potentially bifunctional, while thyA deletion confers resistance to p-aminosalicylic acid | Q35960308 | ||
| Detection of first- and second-line drug resistance in Mycobacterium tuberculosis clinical isolates by pyrosequencing | Q36022970 | ||
| Dynamic population changes in Mycobacterium tuberculosis during acquisition and fixation of drug resistance in patients | Q36368678 | ||
| Double infection with a resistant and a multidrug-resistant strain of Mycobacterium tuberculosis | Q37065017 | ||
| Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis | Q37184072 | ||
| Molecular genetics of para-aminosalicylic acid resistance in clinical isolates and spontaneous mutants of Mycobacterium tuberculosis | Q37190809 | ||
| Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis. | Q37634147 | ||
| Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs | Q37874018 | ||
| Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis | Q39743333 | ||
| Mechanisms of drug resistance in Mycobacterium tuberculosis | Q43253948 | ||
| The tempo and mode of molecular evolution of Mycobacterium tuberculosis at patient-to-patient scale | Q43260011 | ||
| Molecular epidemiology and drug resistance of widespread genotypes of Mycobacterium tuberculosis in northwestern Russia. | Q43269048 | ||
| Exact and complete short-read alignment to microbial genomes using Graphics Processing Unit programming | Q43918351 | ||
| Emergence of extensive drug resistance during treatment for multidrug-resistant tuberculosis | Q43949976 | ||
| Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis | Q44198145 | ||
| In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations | Q44950221 | ||
| Comparison of gyrA gene mutations between laboratory-selected ofloxacin-resistant Mycobacterium tuberculosis strains and clinical isolates | Q46829493 | ||
| Genetic polymorphism in Mycobacterium tuberculosis isolates from patients with chronic multidrug-resistant tuberculosis | Q47348924 | ||
| Tuberculosis ethambutol resistance: concordance between phenotypic and genotypic test results | Q47862617 | ||
| The Beijing genotype is a major cause of drug-resistant tuberculosis in Kazakhstan. | Q47877435 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Mycobacterium tuberculosis | Q130971 |
| Beijing | Q956 | ||
| multiple drug resistance | Q643839 | ||
| whole genome sequencing | Q2068526 | ||
| P304 | page(s) | e82551 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Whole genome sequencing reveals complex evolution patterns of multidrug-resistant Mycobacterium tuberculosis Beijing strains in patients | |
| P478 | volume | 8 |
| Q59200572 | Advances in Tuberculosis Diagnostics |
| Q64097379 | Bacterial Genome-Wide Association Identifies Novel Factors That Contribute to Ethionamide and Prothionamide Susceptibility in Mycobacterium tuberculosis |
| Q37037420 | Baeyer-Villiger Monooxygenases EthA and MymA Are Required for Activation of Replicating and Non-replicating Mycobacterium tuberculosis Inhibitors |
| Q38567338 | Clinical value of whole-genome sequencing of Mycobacterium tuberculosis |
| Q28607255 | Collaborative Effort for a Centralized Worldwide Tuberculosis Relational Sequencing Data Platform |
| Q90100518 | Comparative fitness analysis of D-cycloserine resistant mutants reveals both fitness-neutral and high-fitness cost genotypes |
| Q55339410 | Comparative genomic analysis of multidrug-resistant Streptococcus pneumoniae isolates. |
| Q35915975 | Comparison of Sample Preparation Methods Used for the Next-Generation Sequencing of Mycobacterium tuberculosis |
| Q26851285 | Consequences of genomic diversity in Mycobacterium tuberculosis |
| Q64076239 | Cross-Border Movement of Highly Drug-Resistant Mycobacterium tuberculosis from Papua New Guinea to Australia through Torres Strait Protected Zone, 2010-2015 |
| Q92657500 | Deciphering Within-Host Microevolution of Mycobacterium tuberculosis through Whole-Genome Sequencing: the Phenotypic Impact and Way Forward |
| Q92180644 | Deciphering drug resistance in Mycobacterium tuberculosis using whole-genome sequencing: progress, promise, and challenges |
| Q35644266 | Direct DNA Extraction from Mycobacterium tuberculosis Frozen Stocks as a Reculture-Independent Approach to Whole-Genome Sequencing. |
| Q92667180 | Direct transmission of within-host Mycobacterium tuberculosis diversity to secondary cases can lead to variable between-host heterogeneity without de novo mutation: A genomic investigation |
| Q35232660 | Dissemination of multidrug-resistant tuberculosis in a patient with acute HIV infection |
| Q34930530 | Diversity and evolution of Mycobacterium tuberculosis: moving to whole-genome-based approaches |
| Q42673180 | Diversity and evolution of drug resistance mechanisms in Mycobacterium tuberculosis |
| Q28550914 | Diversity of Mycobacterium tuberculosis across Evolutionary Scales |
| Q64234748 | Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study |
| Q40463792 | Early diagnosis and effective treatment regimens are the keys to tackle antimicrobial resistance in tuberculosis (TB): A report from Euroscicon's international TB Summit 2016. |
| Q62804688 | Evaluation of a gene-by-gene approach for prospective whole-genome sequencing-based surveillance of multidrug resistant Mycobacterium tuberculosis |
| Q38265418 | Evaluation of the Cepheid Xpert MTB/RIF assay |
| Q37605137 | Evaluation of the impact of polyclonal infection and heteroresistance on treatment of tuberculosis patients. |
| Q52707803 | Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care. |
| Q34466858 | Evolution of extensively drug-resistant Mycobacterium tuberculosis from a susceptible ancestor in a single patient |
| Q35917791 | Genetic markers, genotyping methods & next generation sequencing in Mycobacterium tuberculosis |
| Q40936781 | Genome sequencing reveals novel deletions associated with secondary resistance to pyrazinamide in MDR Mycobacterium tuberculosis |
| Q48190673 | Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis |
| Q36844683 | Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistance. |
| Q35812947 | Genomic epidemiology of multidrug-resistant Mycobacterium tuberculosis during transcontinental spread |
| Q28550507 | Identifying Likely Transmission Pathways within a 10-Year Community Outbreak of Tuberculosis by High-Depth Whole Genome Sequencing |
| Q56828266 | Insights into the processes that drive the evolution of drug resistance in Mycobacterium tuberculosis |
| Q103001977 | Integron gene cassettes harboring novel variants of D-alanine-D-alanine ligase confer high-level resistance to D-cycloserine |
| Q26752616 | Interpreting whole genome sequencing for investigating tuberculosis transmission: a systematic review |
| Q40683305 | Longitudinal whole genome analysis of pre and post drug treatment Mycobacterium tuberculosis isolates reveals progressive steps to drug resistance |
| Q89834670 | Metabolic Changes of Mycobacterium tuberculosis during the Anti-Tuberculosis Therapy |
| Q28389409 | Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria |
| Q47173840 | Multi-clonal evolution of multi-drug-resistant/extensively drug-resistant Mycobacterium tuberculosis in a high-prevalence setting of Papua New Guinea for over three decades |
| Q61814968 | Mycobacterial genomics and structural bioinformatics: opportunities and challenges in drug discovery |
| Q49289731 | Mycobacterium tuberculosis Acquires Limited Genetic Diversity in Prolonged Infections, Reactivations and Transmissions Involving Multiple Hosts |
| Q38616709 | PathoBacTyper: A Web Server for Pathogenic Bacteria Identification and Molecular Genotyping |
| Q30927278 | PhyResSE: a Web Tool Delineating Mycobacterium tuberculosis Antibiotic Resistance and Lineage from Whole-Genome Sequencing Data |
| Q38966881 | Potential for adaptation overrides cost of resistance. |
| Q37132034 | Rapid Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates Directly from Clinical Samples by Use of Amplicon Sequencing: a Proof-of-Concept Study |
| Q41991754 | Role of alanine racemase mutations in Mycobacterium tuberculosis D-cycloserine resistance |
| Q90286638 | Sources of multi-drug resistance in patients with previous isoniazid resistant tuberculosis identified using whole genome sequencing: A longitudinal cohort study |
| Q47851713 | Strain Diversity and the Evolution of Antibiotic Resistance |
| Q47632792 | The Evolution of Strain Typing in the Mycobacterium tuberculosis Complex |
| Q35765601 | The association between sterilizing activity and drug distribution into tuberculosis lesions |
| Q33576860 | The within-host population dynamics of Mycobacterium tuberculosis vary with treatment efficacy |
| Q38210265 | Totally drug-resistant tuberculosis and adjunct therapies. |
| Q37247747 | Tracing Mycobacterium tuberculosis transmission by whole genome sequencing in a high incidence setting: a retrospective population-based study in East Greenland |
| Q27023437 | Translating genomics research into control of tuberculosis: lessons learned and future prospects |
| Q36094210 | Translating the Tuberculosis Research Agenda: Much Accomplished, but Much More to Be Done |
| Q54988423 | Unique Features and Anti-microbial Targeting of Folate- and Flavin-Dependent Methyltransferases Required for Accurate Maintenance of Genetic Information. |
| Q34659483 | VTBuilder: a tool for the assembly of multi isoform transcriptomes. |
| Q42146421 | Whole genome sequence analysis of multidrug-resistant Mycobacterium tuberculosis Beijing isolates from an outbreak in Thailand |
| Q64272074 | Whole genome sequencing Mycobacterium tuberculosis directly from sputum identifies more genetic diversity than sequencing from culture |
| Q30202327 | Whole genome sequencing reveals genomic heterogeneity and antibiotic purification in Mycobacterium tuberculosis isolates |
| Q36096208 | Whole genome sequencing reveals mycobacterial microevolution among concurrent isolates from sputum and blood in HIV infected TB patients |
| Q36869848 | Whole genome sequencing to complement tuberculosis drug resistance surveys in Uganda |
| Q92462936 | Whole-genome sequencing for rapid, reliable and routine investigation of Mycobacterium tuberculosis transmission in local communities |
| Q36333485 | Within patient microevolution of Mycobacterium tuberculosis correlates with heterogeneous responses to treatment |
| Q42763782 | dfrA thyA Double Deletion in para-Aminosalicylic Acid-Resistant Mycobacterium tuberculosis Beijing Strains |
Search more.